Abstract
Angiogenesis, the formation of new blood vessels, is an essential part of normal physiological processes such as embryonic growth, wound healing, and the cyclical development of the uterine endometrium. It also occurs in a variety of pathological conditions including arthritis, diabetic retinopathy, and tumour growth (Folkman and Cotran, 1976). Early observers had noted a proliferation of blood vessels in the vicinity of such tumours (see Vallee et al., 1985), and it was later proposed by Folkman (1971) that these tumours are totally dependent on angiogenesis for growth beyond a diameter of 1–2 mm. Angiogenesis is also thought to be a prerequisite for the development of metastases since it provides the means whereby cells disseminate from the original primary tumour.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Acharya, K. R., Shapiro, R., Allen, S. C., Riordan, J. F. and Vallee, B. L.1994, Crystal structure of human angiogenin reveals the structural basis for its functional divergence from ribonuclease. Proc. Natl. Acad. Sci. USA, 91: 2915–2919.
Acharya, K. R., Shapiro, R., Riordan, J. F. and Vallee, B. L. 1995, Crystal structure of bovine angiogenin at 1.5 Å resolution. Proc. Natl. Acad. Sci. USA, 92: 2949–2953.
Allen, S. C., Acharya, K. R., Palmer, K. A., Shaprio, R., Vallee, B. L. and Scheraga, H. A. 1994, A comparison of the predicted and X-ray structures of angiogenin. Implications for further studies of model building of homologous proteins. J. Prot. Chem., 13: 649–658.
Borah, B., Chen, C. W., Egan, W., Miller, M., Wlodawer, A. and Cohen, J. S. 1985, Nuclear magnetic resonance and neutron diffraction studies of the complex of RNase A with uridine vanadate, a transition state analog. Biochemistry 24: 2058–2067.
Curran, T. P., Shapiro, R. and Riordan, J. F. 1993, Alteration of the enzymatic specificity of human angiogenin by site-directed mutagenesis. Biochemistry, 32: 2307–2313.
Fett, J. W., Strydom, D. J., Lobb, R. R., Alderman, E. M., Bethune, J. L., Riordan, J. F. and Vallee, B. L. 1985, Isolation and characterization of angiogenin, an angiogenic protein from human carcinoma cells. Biochemistry, 24: 5480–5486.
Folkman, J. and Cotran, R. S. 1976, Relation of vascular proliferation to tumor growth. Int. Rev. Exp. Path., 16: 207–248.
Folkman, J. 1971, Tumor angiogenesis: Therapeutic implications. N Engl. J. Med., 285: 1182–1186.
Folkman, J. and Shing, Y. 1992, Angiogenesis. J. Biol. Chem. 256: 10931–10934.
Hallahan, T. W., Shapiro, R. and Vallee, B. L.1991, Dual site model for the organogenic activity of angiogenin. Proc. Natl. Acad. Sci. USA, 88: 2222–2226.
Hallahan, T. W., Shapiro, R. and Vallee, B. L. 1992, Importance of asparagine-61 and asparagine -109 to the angiogenic activity of human angiogenin. Biochemistry, 31: 8002–8029.
Harper, J. W. and Vallee, B. L. 1988, Mutagenesis of aspartic acid-116 enhances the ribonucleolytic activity and angiogenic potency of angiogenin. Proc. Natl. Acad. Sci. USA, 85: 7139–7143.
Harper, J. W. and Vallee, B. L. 1989, A covalent angiogenin/ribonuclease hybrid with a fourth disulfide bond generated by regional mutagenesis. Biochemistry, 28: 1875–1884.
Hu, G.-F., Riordan, J. F. and Vallee, B. L. 1994, Angiogenin promotes invasiveness of cultured endothelial cells by stimulation of cell-associated proteolytic activities. Proc. Natl. Acad. Sci. USA, 81: 12096–12100.
Hu, G.-F., Riordan, J. F. and Vallee, B. L. 1997, A putative angiogenin receptor in angiogenin-responsive human endothelial cells. Proc. Natl. Acad. Sci. USA, 94: 2204–2209.
King, T.V. and Vallee, B.L. 1991, Neovascularization of the meniscus with angiogenin. J. Bone Joint Surg., 73-B: 587–590.
Kraulis, P. J. 1991. MOLSCRIPT — a program to produce both detailed and schematic plots of protein structures. J. Appl. Crystallogr., 24: 946–950.
Leonidas, D. D., Shapiro, R., Irons, L. L., Russo, N. and Acharya, K. R. 1997, Crystal structures of Ribonuclease A complexes with 5′-Diphosphoadenosine 3′-phosphate and 5′-Diphosphoadenosine 2′-phosphate at 1.7 Å resolution. Biochemistry, 36: 5578–5588.
Lequin, O., Albaret, C., Bontems, F., Spik, G. and Lallemand, J. Y. 1996, Solution structure of bovine angiogenin by 1H nuclear magentic resonance spectroscopy. Biochemistry, 35, 8870–8880.
Lee, F.S., Shapiro, R. and Vallee, B. L. 1989, Tight-binding inhibition of angiogenin and ribonuclease A by placental ribonuclease inhibitor. Biochemistry, 28: 225–230.
Lee, F. S. and Vallee, B. L. 1989, Binding of placental ribonuclease inhibitor to the active site of angiogenin. Biochemistry, 28: 3556–3561.
Moroianu, J. and Riordan, J.F. 1994, Nuclear translocation of angiogenin in proliferating endothelial cells is essential to its angiogenic activity. Proc. Natl. Acad. Sci. USA., 91: 1677–1681.
Olson, K. A., French, T. C., Vallee, B. L. and Fett, J. W. 1994, A monoclonal antibody to human angiogenin suppresses tumor growth in athymic mice. Cancer Res., 54: 4576–4579.
Olson, K. A., Fett, J. W., French, T. C., Key, M. E. and Vallee, B. L. 1995, Angiogenin antagonists prevent tumor growth in vivo. Proc. Natl. Acad. Sci. USA, 92: 442–446.
Olson, K. A. and Fett, J. W. 1996, Prostatic carcinoma therapy with angiogenin antagonists. Proc. Amer. Assoc. Cane. Res., 37: 57.
O’Reilly, M. S., Holmgren, L., Shing, Y., Chen, C., Rosenthal, R. A., Moses, M., Lane, W. S., Cao, Y., Sage, E. H. and Folkman, J. 1994, Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell, 79: 315–328.
O’Reilly, M. S., Boehm, T., Shing, Y., Fukai, N., Vasios, G., Lane, W. S., Flynn, E., Birkhead, J. R., Olsen, B. R. and Folkman, J. 1997, Endostatin: An endogenous inhibitor of angiogenesis and tumor growth. Cell, 88: 277–285.
Polakowski, I. J., Lewis, M. K., Muthukkaruppan, V., Erdman, B., Kubai, L. and Auerbach, R. 1993, A ribonuclease inhibitor expresses anti-angiogenic properties and leads to reduced tumor growth in mice. Am. J. Pathol., 143: 507–517.
Russo, N., Shapiro, R., Acharya, K. R., Riordan, J. F. and Vallee, B. L. 1994, The role of glutamine-117 in the ribonucleolytic activity of human angiogenin. Proc. Natl. Acad. Sci. USA, 91:2920–2924.
Russo, N., Acharya, K. R., Vallee, B. L. and Shapiro, R. 1996, A combined kinetic and modeling study of the catalytic center subsites of human angiogenin. Proc. Natl. Acad. Sci. USA, 93: 804–808.
Shapiro, R., Fox, E. A. and Riordan, J. F. 1989, Role of lysines and human angiogenin -chemical modification and site-directed mutagenesis. Biochemistry, 28: 1726–1732.
Shapiro, R., Harper, J.W., Fox, E. A., Jensen, H-W., Hein, F. and Uhlmann, E. 1988, Expression of Met-(-1) angiogenin in Escherichia coli. Anal. Biochem., 175: 450–461.
Shapiro, R., Strydom, D. J., Olson, K.A. and Vallee, B.L. 1987, Isolation of angiogenin from natural human plasma. Biochemistry, 26: 5141–5146.
Shapiro, R. and Vallee, B. L. 1987, Human placental ribonuclease inhibitor abolishes both angiogenic and ribonucleolytic activities of angiogenin. Proc. Natl. Acad. Sci. USA, 84: 2238–2241.
Shapiro, R. and Vallee, B. L. 1989, Site-directed mutagenesis of histidine-13 and histidine-114 of human angiogenin. Alanine derivatives inhibit angiogenin-induced angiogenesis. Biochemistry, 28: 7401–7408.
Shapiro, R. and Vallee, B. L. 1992, Identification of functional arginines in human angiogenin by site-directed mutagenesis. Biochemistry, 31: 12477–12485.
Soncin, F. 1992, Angiogenin supports endothelial and fibroblast cell adhesion. Proc. Natl. Acad. Sci. USA, 89: 2232–2236.
Strydom, D. J., Fett, J. W., Lobb, R. R., Alderman, E. M., Bethune, J. L., Riordan, J. F. and Vallee, B. L., 1985, Amino-acid sequence of human-tumor derived angiogenin. Biochemistry, 24: 5486–5494.
Vallee, B. L., Riordan, J. F., Lobb, R. R., Higachi, N., Fett, J. W., Crossley, G., Bühler, R., Budzik, G., Breddam, K., Bethune, J. L. and Alderman, E. M. 1985, Tumor-derived angiogenesis factors from rat Walker 256 carcinoma: an experimantal investigation and review. Experientia, 41: 1–15.
Waldmann, T.A. 1991, Monoclonal antibodies in diagnosis and therapy. Science, 252: 1657–1661.
Wlodawer, A., Bott, R. and Sjolin, L. 1982, The refined crystal structure of Ribonuclease A at 2.0 Å resolution. J. Biol. Chem., 257: 1325–1332.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1998 Springer Science+Business Media New York
About this chapter
Cite this chapter
Acharya, K.R., Leonidas, D.D., Papageorgiou, A.C., Russo, N., Shapiro, R. (1998). Structural Studies on Angiogenin, a Protein Implicated in Neovascularization during Tumour Growth. In: Maragoudakis, M.E. (eds) Angiogenesis. NATO ASI Series, vol 298. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-9185-3_19
Download citation
DOI: https://doi.org/10.1007/978-1-4757-9185-3_19
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4757-9187-7
Online ISBN: 978-1-4757-9185-3
eBook Packages: Springer Book Archive